ATE16244T1 - Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen. - Google Patents

Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen.

Info

Publication number
ATE16244T1
ATE16244T1 AT82401343T AT82401343T ATE16244T1 AT E16244 T1 ATE16244 T1 AT E16244T1 AT 82401343 T AT82401343 T AT 82401343T AT 82401343 T AT82401343 T AT 82401343T AT E16244 T1 ATE16244 T1 AT E16244T1
Authority
AT
Austria
Prior art keywords
polyosides
production
capsular
bacteriae
give
Prior art date
Application number
AT82401343T
Other languages
English (en)
Inventor
Demetre Institut De Yavordios
Foch Avenue
Mireille Institut De Re Cousin
Original Assignee
Berri Balzac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berri Balzac filed Critical Berri Balzac
Application granted granted Critical
Publication of ATE16244T1 publication Critical patent/ATE16244T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
AT82401343T 1981-07-30 1982-07-19 Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen. ATE16244T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8114842A FR2510606A1 (fr) 1981-07-30 1981-07-30 Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
EP82401343A EP0071515B1 (de) 1981-07-30 1982-07-19 Verfahren zur Herstellung von Kapselpolyosiden, so erhaltene Kapselpolyosiden und ihre Verwendung für die Herstellung von Vakzinen

Publications (1)

Publication Number Publication Date
ATE16244T1 true ATE16244T1 (de) 1985-11-15

Family

ID=9261011

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82401343T ATE16244T1 (de) 1981-07-30 1982-07-19 Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen.

Country Status (11)

Country Link
EP (1) EP0071515B1 (de)
AT (1) ATE16244T1 (de)
CA (1) CA1206905A (de)
DD (1) DD202623A5 (de)
DE (1) DE3267160D1 (de)
DK (1) DK327182A (de)
ES (1) ES8305827A1 (de)
FR (1) FR2510606A1 (de)
IE (1) IE53582B1 (de)
NO (1) NO159394C (de)
PT (1) PT75301B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683844D1 (de) * 1986-03-27 1992-03-19 Schweiz Serum & Impfinst Impfstoff des klebsiella kapsulpolysaccharids.
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
EP1967591A3 (de) * 2000-03-16 2008-12-03 The Children's Hospital Of Philadelphia Methode zur Bestimmung der Nützlichkeit einer Testsubstanz zur Linderung einer Pneumokokken-Infektion in einem Tier
NZ511680A (en) 2001-05-14 2004-07-30 Univ Waikato Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases
GB0522303D0 (en) * 2005-11-01 2005-12-07 Chiron Srl Culture method
WO2008129559A2 (en) 2007-04-23 2008-10-30 Serum Institute Of India Ltd Antigenic polysaccharides and process for their preparation
WO2011148382A1 (en) 2010-05-28 2011-12-01 Biological E Limited An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol.
WO2011151841A1 (en) * 2010-05-31 2011-12-08 Panacea Biotec Limited Fermentation process for streptococcus pneumoniae
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CA3048981A1 (en) 2016-12-30 2018-07-05 Sutrovax, Inc. Polypeptide-antigen conjugates with non-natural amino acids
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2024062494A1 (en) 2022-09-19 2024-03-28 Biological E Limited Method for the purification of capsular polysaccharides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166963A (en) * 1936-11-19 1939-07-25 Sharp & Dohme Inc Antigenic polysaccharide complex
US2528972A (en) * 1947-05-15 1950-11-07 Western Reserve University Prophylactic toxoid compound and method of making same
FR2407262A1 (fr) * 1977-10-27 1979-05-25 Cassenne Lab Sa Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4307080A (en) * 1979-09-24 1981-12-22 Merck & Co., Inc. Meningitis vaccine
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries

Also Published As

Publication number Publication date
IE821705L (en) 1983-01-30
FR2510606A1 (fr) 1983-02-04
CA1206905A (en) 1986-07-02
EP0071515A1 (de) 1983-02-09
DK327182A (da) 1983-01-31
FR2510606B1 (de) 1984-10-26
NO159394C (no) 1988-12-21
DD202623A5 (de) 1983-09-28
IE53582B1 (en) 1988-12-21
PT75301B (fr) 1984-07-31
EP0071515B1 (de) 1985-10-30
PT75301A (fr) 1982-08-01
ES514496A0 (es) 1983-04-16
DE3267160D1 (en) 1985-12-05
ES8305827A1 (es) 1983-04-16
NO159394B (no) 1988-09-12
NO822592L (no) 1983-01-31

Similar Documents

Publication Publication Date Title
ATE91155T1 (de) Verfahren zur bereitung von nukleinsaeure fuer hybridisierung.
ATE16244T1 (de) Verfahren zur herstellung von kapselpolyosiden, so erhaltene kapselpolyosiden und ihre verwendung fuer die herstellung von vakzinen.
DE3784860D1 (de) Verbessertes verfahren zur transformation von pflanzlichen protoplasten.
DE69114311D1 (de) Verfahren zur Herstellung und Extrahierung von Antioxydantien aus einer Mikroorganismenkultur und Fotobioreaktor zur Durchführung des Verfahrens.
EP0387567A3 (de) Amphoterer Elektrolyt, Verfahren zur Herstellung und Entwässerungsmittel für organische Schlämme
DE69112463D1 (de) Vorrichtung zur Herstellung von Monokristallen nach dem Czochralski-Verfahren.
ATE18776T1 (de) Verfahren und vorrichtung zur zuechtung von mikroorganismen.
DE69109886D1 (de) Verfahren zur Herstellung von humanem Faktor VIII und dessen Analogen.
FR2545099B1 (fr) Nouvelle souche de trichoderma harzianum procede d'isolement de cette souche, procede de culture de cette souche, nouveaux peptides produits par cette souche, et application de cette souche et ces nouveaux peptides ou du produit obtenu par le procede de culture comme moyen de lutte biologique sous forme de produit phytosanitaire
PT80542A (de) Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
ATE92075T1 (de) Verfahren zur gewinnung aktiver proteine aus einer biologisch inaktiven form.
DE68912236D1 (de) Verfahren zur Herstellung von hochgradig ungesättigten Fettsäuren.
AT361906B (de) Verfahren zur herstellung von neuen 2,4,6- trijodbenzonitrilen sowie deren estern, saeure- amiden und salzen
DE69116240D1 (de) Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung
ATE21033T1 (de) Verfahren zur herstellung eines immunogens aus pasteurella multocida.
DE68904131D1 (de) Schweinenierenzellkultur und ihre verwendung fuer die herstellung von vakzinen.
EP0391345A3 (de) Verfahren zur Herstellung optisch aktiver Substanzen
DE69015499D1 (de) Verfahren zur Herstellung von Castanosperminestern.
ATE2339T1 (de) Verfahren zur herstellung von sphingomyelinase, sphingomyelinase und deren verwendung.
JPS5675095A (en) Preparation of heat-resistant acetic acid kinase
ATE112170T1 (de) Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
RU93028311A (ru) Способ получения биологически активных веществ из биомассы культивируемых клеток растений
JPS5682095A (en) Purification of fatty acid produced through fermentation process
RU94025893A (ru) Способ выделения биологически активных веществ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee